<DOC>
	<DOCNO>NCT00699816</DOCNO>
	<brief_summary>To prove efficacy safety 'Green Cross CELL* Immuncell-LC group ' superior 'non-treatment group ( Control group ) ' patient undergone curative resection ( PEIT , RFA operation ) hepatocellular carcinoma Korea</brief_summary>
	<brief_title>Efficacy Safety Immuncell-LC Group Non-treatment Group Hepatocelluar Carcinoma Patients</brief_title>
	<detailed_description>Multicenter , randomize , open-labeled phase 3 clinical trial .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Prior test , patient fully explain purpose/ content characteristic test medication , patient ( ) self , guardian legal representative sign write consent . The patient 20 less 80 year old The patient diagnose hepatocellular carcinoma pathological/ radiological test ( ) stage I II . ( refer attach file 10 ) . Hepatocellular carcinoma show radiological test ; dynamic CT , dynamic MRI angiography . ChildPugh Score le 6 ( refer attach file 7 ) No matter patient treat , ( ) tumor totally remove curative resection ( PEIT , RFA operation ) 12 week . ( base agreement date write consent ) The tumor 's removal perfectly confirm pathological radiological test mention method 3 ) least 4 week later . ECOG Performance status ( ECOGPS ) less 1 equal ( refer exhibit 8 ) Patient 's remain lifetime expect least 3 month . Patient meet condition blood test , kidney liver function test : Reevaluation possible screen Leukocyte count big ( 3 multiply 109/L ) Absolute Neutrophil Count ( ANC ) big equal 1,000/ÂµL Hemoglobin big equal 8.5 g/dL Thrombocyte count big ( 5 multiply 1010/L ) BUN serum Creatinine le equal 1.5 multiply normal upperlimit No disease abdominal extrahepatic transfer confirm abdominal CT/ MRI Hepatocellular carcinoma transfer pathological/ radiological test ( Stage III Stage IV , refer exhibit 10 ) The carcinoma invade main portal vein major branch hepatic vein ChildPugh score 6 Patient serious problem pulmonary function sub investigator 's opinion Patient disease history immune deficiency ( bad immunotherapy ) autoimmune disease ( ex . arthritis rheumatism , Burger 's disease , multiple sclerosis adolescentoccurred insulin dependent diabetes ) Diagnosed immune deficiency patient Patient disease history malignant tumor within 5 year clinical trial . ( except skin cancer , local prostate cancer carcinoma situ uterine cervix Patient anticancer medication clinical trial Patient serious disease organ tumor resection . Patient serious allergichistory sub investigator 's opinion Patient serious mental disease sub investigator 's opinion Pregnant woman , nurse mother intention pregnant clinical test Patient participate clinical trial within 4 week clinical trial Patient incongruent clinical trial sub investigator 's opinion .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>